Zydus Baddi Plant Receives Four Observations in USFDA Inspection

Zydus Lifesciences had its Baddi plant inspected by the US Food and Drug Administration (USFDA).

The inspection, which ran from August 4th to August 13th, 2025, resulted in four observations.

These observations are not related to data integrity.

The company's shares also saw a rise in value, increasing by 3.45% on the BSE.

This news follows a previous successful inspection at another Zydus plant.